Holazo A A, Choma N, Brown S Y, Lee L F, Wills R J
Department of Drug Metabolism, Hoffmann-La Roche Inc., Nutley, New Jersey 07110.
Antimicrob Agents Chemother. 1989 Jun;33(6):820-3. doi: 10.1128/AAC.33.6.820.
Twenty-three healthy male and female subjects received single 100-mg oral doses of rimantadine hydrochloride on two occasions in an open-label, sequential design with a 6-day washout between doses. The first dose of rimantadine was administered alone, and the second dose was administered concomitantly with cimetidine (300 mg four times a day for 6 days). Blood and urine samples were collected, and rimantadine concentrations were determined by a gas-chromatographic--mass-spectrometric method. There were no changes in the rate of absorption and the renal clearance of rimantadine when it was administered with cimetidine. Both parametric and nonparametric tests showed significant differences in the area under the concentration-time curve, apparent total clearance, and elimination rate constant between the treatments (P less than 0.01). The apparent total clearance was reduced by 18%, resulting in higher values for the area under the concentration-time curve in the presence of cimetidine. However, the wide therapeutic index of rimantadine renders these changes of little, if any, clinical consequence.
23名健康男性和女性受试者,在开放标签、序贯设计中,分两次接受了100毫克盐酸金刚烷胺的单次口服剂量,两次给药之间有6天的洗脱期。第一次单独给予金刚烷胺剂量,第二次与西咪替丁(每天4次,每次300毫克,共6天)同时给药。采集血液和尿液样本,并用气相色谱 - 质谱法测定金刚烷胺浓度。当金刚烷胺与西咪替丁合用时,其吸收速率和肾清除率没有变化。参数检验和非参数检验均显示,两种治疗方法在浓度 - 时间曲线下面积、表观总清除率和消除速率常数方面存在显著差异(P小于0.01)。表观总清除率降低了18%,导致在使用西咪替丁时浓度 - 时间曲线下面积值更高。然而,金刚烷胺较宽的治疗指数使得这些变化即便有临床影响也很小。